Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever.

Boisen ML, Hartnett JN, Shaffer JG, Goba A, Momoh M, Sandi JD, Fullah M, Nelson DKS, Bush DJ, Rowland MM, Heinrich ML, Koval AP, Cross RW, Barnes KG, Lachenauer AE, Lin AE, Nekoui M, Kotliar D, Winnicki SM, Siddle KJ, Gbakie M, Fonnie M, Koroma VJ, Kanneh L, Kulakosky PC, Hastie KM, Wilson RB, Andersen KG, Folarin OO, Happi CT, Sabeti PC, Geisbert TW, Saphire EO, Khan SH, Grant DS, Schieffelin JS, Branco LM, Garry RF.

Sci Rep. 2018 Apr 12;8(1):5939. doi: 10.1038/s41598-018-24246-w.

2.

Dollars and Deadlines: Rule Reforms in Short Time Frames.

Schonfeld T, Gormley M, Nelson DK.

Am J Bioeth. 2017 Jul;17(7):62-64. doi: 10.1080/15265161.2017.1328533. No abstract available.

PMID:
28661745
3.

Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.

Boisen ML, Cross RW, Hartnett JN, Goba A, Momoh M, Fullah M, Gbakie M, Safa S, Fonnie M, Baimba F, Koroma VJ, Geisbert JB, McCormick S, Nelson DK, Millett MM, Oottamasathien D, Jones AB, Pham H, Brown BL, Shaffer JG, Schieffelin JS, Kargbo B, Gbetuwa M, Gevao SM, Wilson RB, Pitts KR, Geisbert TW, Branco LM, Khan SH, Grant DS, Garry RF.

J Infect Dis. 2016 Oct 15;214(suppl 3):S203-S209. Epub 2016 Aug 11.

4.

Reflections From Fellow Feds: Addressing Delays in Oversight of Federally Funded Research.

Schonfeld T, Nelson DK.

Am J Bioeth. 2016 Aug;16(8):50-2. doi: 10.1080/15265161.2016.1187216. No abstract available.

PMID:
27366852
5.

Public Comments on Proposed Regulatory Reforms That Would Impact Biospecimen Research: The Good, the Bad, and the Puzzling.

Cadigan RJ, Nelson DK, Henderson GE, Nelson AG, Davis AM.

IRB. 2015 Sep-Oct;37(5):1-10. No abstract available.

PMID:
26523321
6.

A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing.

Berg JS, Foreman AK, O'Daniel JM, Booker JK, Boshe L, Carey T, Crooks KR, Jensen BC, Juengst ET, Lee K, Nelson DK, Powell BC, Powell CM, Roche MI, Skrzynia C, Strande NT, Weck KE, Wilhelmsen KC, Evans JP.

Genet Med. 2016 May;18(5):467-75. doi: 10.1038/gim.2015.104. Epub 2015 Aug 13.

7.

The irregular terrain of human subjects research regulations. Commentary.

Forster D, Nelson DK, Borasky D, Botkin JR.

Hastings Cent Rep. 2014 Jul-Aug;44(4 Spec No):S29-30. doi: 10.1002/hast.338. No abstract available.

PMID:
25043469
8.

Obtaining consent from both parents for pediatric research: what does "reasonably available" mean?

Nelson DK, Skinner D, Guarda S, Choudhury S, Sideris J, Barnum L, Ten Haagen K, Heyward Q, Bailey DB Jr.

Pediatrics. 2013 Jan;131(1):e223-9. doi: 10.1542/peds.2012-1278. Epub 2012 Dec 24.

9.

Structure and function of assemblages of Bacteria and Archaea in model anaerobic aquifer columns: can functional instability be practically beneficial?

Nelson DK, Lapara TM, Novak PJ.

Environ Sci Technol. 2012 Sep 18;46(18):10137-44. doi: 10.1021/es300652z. Epub 2012 Aug 27.

PMID:
22873515
10.

IRB chairs' perspectives on genotype-driven research recruitment.

Beskow LM, Namey EE, Miller PR, Nelson DK, Cooper A.

IRB. 2012 May-Jun;34(3):1-10. No abstract available.

11.

Recommendations for ethical approaches to genotype-driven research recruitment.

Beskow LM, Fullerton SM, Namey EE, Nelson DK, Davis AM, Wilfond BS.

Hum Genet. 2012 Sep;131(9):1423-31. doi: 10.1007/s00439-012-1177-z. Epub 2012 May 24.

12.

Research participants' perspectives on genotype-driven research recruitment.

Beskow LM, Namey EE, Cadigan RJ, Brazg T, Crouch J, Henderson GE, Michie M, Nelson DK, Tabor HK, Wilfond BS.

J Empir Res Hum Res Ethics. 2011 Dec;6(4):3-20. doi: 10.1525/jer.2011.6.4.3.

13.

Continuous symmetry of C60 fullerene and its derivatives.

Sheka EF, Razbirin BS, Nelson DK.

J Phys Chem A. 2011 Apr 21;115(15):3480-90. doi: 10.1021/jp109128v. Epub 2011 Mar 30.

PMID:
21449547
14.

Effects of ethanol-based fuel contamination: microbial community changes, production of regulated compounds, and methane generation.

Nelson DK, Lapara TM, Novak PJ.

Environ Sci Technol. 2010 Jun 15;44(12):4525-30. doi: 10.1021/es903940q.

PMID:
20481624
15.

Getting from A to IRB: developing an institutional review board at a historically black university.

Howard DL, Boyd CL, Nelson DK, Godley P.

J Empir Res Hum Res Ethics. 2010 Mar;5(1):75-81. doi: 10.1525/jer.2010.5.1.75.

16.

Clinical trials and medical care: defining the therapeutic misconception.

Henderson GE, Churchill LR, Davis AM, Easter MM, Grady C, Joffe S, Kass N, King NM, Lidz CW, Miller FG, Nelson DK, Peppercorn J, Rothschild BB, Sankar P, Wilfond BS, Zimmer CR.

PLoS Med. 2007 Nov 27;4(11):e324. No abstract available.

17.

Applying research ethics guidelines: the view from a sub-saharan research ethics committee.

Henderson GE, Corneli AL, Mahoney DB, Nelson DK, Mwansambo C.

J Empir Res Hum Res Ethics. 2007 Jun;2(2):41-8. doi: 10.1525/jer.2007.2.2.41.

18.

FGFR1 function at the earliest stages of mouse limb development plays an indispensable role in subsequent autopod morphogenesis.

Li C, Xu X, Nelson DK, Williams T, Kuehn MR, Deng CX.

Development. 2005 Nov;132(21):4755-64. Epub 2005 Oct 5.

19.

Therapeutic misconception in early phase gene transfer trials.

Henderson GE, Easter MM, Zimmer C, King NM, Davis AM, Rothschild BB, Churchill LR, Wilfond BS, Nelson DK.

Soc Sci Med. 2006 Jan;62(1):239-53. Epub 2005 Jul 5.

PMID:
16000230
20.

Common (mis)perceptions about IRB review of human subjects research.

Lynn MR, Nelson DK.

Nurs Sci Q. 2005 Jul;18(3):264-70.

PMID:
15976051
21.

Preliminary evaluation of whole-blood gamma interferon release for clinical assessment of cellular immunity in patients with active coccidioidomycosis.

Ampel NM, Nelson DK, Chavez S, Naus KA, Herman AB, Li L, Simmons KA, Pappagianis D.

Clin Diagn Lab Immunol. 2005 Jun;12(6):700-4.

22.

Consent forms and the therapeutic misconception: the example of gene transfer research.

King NM, Henderson GE, Churchill LR, Davis AM, Hull SC, Nelson DK, Parham-Vetter PC, Rothschild BB, Easter MM, Wilfond BS.

IRB. 2005 Jan-Feb;27(1):1-8. No abstract available.

PMID:
15835063
23.

The mannose receptor mediates the cellular immune response in human coccidioidomycosis.

Ampel NM, Nelson DK, Li L, Dionne SO, Lake DF, Simmons KA, Pappagianis D.

Infect Immun. 2005 Apr;73(4):2554-5.

24.

Uncertain benefit: investigators' views and communications in early phase gene transfer trials.

Henderson GE, Davis AM, King NM, Easter MM, Zimmer CR, Rothschild BB, Wilfond BS, Nelson DK, Churchill LR.

Mol Ther. 2004 Aug;10(2):225-31.

26.
27.

Assessing benefits in clinical research: why diversity in benefit assessment can be risky.

Churchill LR, Nelson DK, Henderson GE, King NM, Davis AM, Leahey E, Wilfond BS.

IRB. 2003 May-Jun;25(3):1-8. No abstract available.

PMID:
14569987
28.

The cost of operating institutional review boards (IRBs).

Wagner TH, Bhandari A, Chadwick GL, Nelson DK.

Acad Med. 2003 Jun;78(6):638-44.

PMID:
12805049
29.

Toward protecting the safety of participants in clinical trials.

Califf RM, Morse MA, Wittes J, Goodman SN, Nelson DK, DeMets DL, Iafrate RP, Sugarman J.

Control Clin Trials. 2003 Jun;24(3):256-71.

PMID:
12757992
30.

Serine protease inhibitors modulate smoke-induced chemokine release from human lung fibroblasts.

Numanami H, Koyama S, Nelson DK, Hoyt JC, Freels JL, Habib MP, Amano J, Haniuda M, Sato E, Robbins RA.

Am J Respir Cell Mol Biol. 2003 Nov;29(5):613-9. Epub 2003 May 8.

PMID:
12738688
31.

Serine protease inhibitors modulate chemotactic cytokine production by human lung fibroblasts in vitro.

Numanami H, Koyama S, Sato E, Haniuda M, Nelson DK, Hoyt JC, Freels JL, Habib MP, Robbins RA.

Am J Physiol Lung Cell Mol Physiol. 2003 May;284(5):L882-90. Epub 2002 Dec 13.

32.

Peroxynitrite enhances interleukin-10 reduction in the release of neutrophil chemotactic activity.

Numanami H, Nelson DK, Hoyt JC, Freels JL, Habib M, Amano J, Haniuda M, Koyama S, Robbins RA.

Am J Respir Cell Mol Biol. 2003 Aug;29(2):239-44. Epub 2003 Mar 6.

PMID:
12626343
33.

Enhanced activity of human IL-10 after nitration in reducing human IL-1 production by stimulated peripheral blood mononuclear cells.

Freels JL, Nelson DK, Hoyt JC, Habib M, Numanami H, Lantz RC, Robbins RA.

J Immunol. 2002 Oct 15;169(8):4568-71.

34.

Peroxynitrite inhibits inducible (type 2) nitric oxide synthase in murine lung epithelial cells in vitro.

Robinson VK, Sato E, Nelson DK, Camhi SL, Robbins RA, Hoyt JC.

Free Radic Biol Med. 2001 May 1;30(9):986-91.

PMID:
11316578
35.

Inflammatory cytokines modulate eotaxin release by human lung fibroblast cell line.

Sato E, Nelson DK, Koyama S, Hoyt JC, Robbins RA.

Exp Lung Res. 2001 Mar;27(2):173-83.

PMID:
11258804
36.

Erythromycin modulates eosinophil chemotactic cytokine production by human lung fibroblasts in vitro.

Sato E, Nelson DK, Koyama S, Hoyt JC, Robbins RA.

Antimicrob Agents Chemother. 2001 Feb;45(2):401-6.

37.

Reactive oxygen and nitrogen metabolites modulate fibronectin-induced fibroblast migration in vitro.

Sato E, Koyama S, Camhi SL, Nelson DK, Robbins RA.

Free Radic Biol Med. 2001 Jan 1;30(1):22-9.

PMID:
11134892
38.

Helicobacter pylori and dyspepsia: a population-based study of the organism and host.

Locke CR 3rd, Talley NJ, Nelson DK, Haruma K, Weaver AL, Zinsmeister AR, Melton LJ 3rd.

Am J Gastroenterol. 2000 Aug;95(8):1906-13.

PMID:
10950034
39.

Bradykinin stimulates eotaxin production by a human lung fibroblast cell line.

Sato E, Nelson DK, Koyama S, Hoyt JC, Robbins RA.

J Allergy Clin Immunol. 2000 Jul;106(1 Pt 1):117-23.

PMID:
10887314
40.

Changes in metabolism of TRH in euthyroid sick syndrome.

Duntas LH, Nguyen TT, Keck FS, Nelson DK, DiStefano JJ 3rd.

Eur J Endocrinol. 1999 Oct;141(4):337-41.

41.

Efficacy of conventional endoscopic disinfection and sterilization methods against Helicobacter pylori contamination.

Cronmiller JR, Nelson DK, Jackson DK, Kim CH.

Helicobacter. 1999 Sep;4(3):198-203.

PMID:
10469194
42.

Antimicrobial efficacy of endoscopic disinfection procedures: a controlled, multifactorial investigation.

Cronmiller JR, Nelson DK, Salman G, Jackson DK, Dean RS, Hsu JJ, Kim CH.

Gastrointest Endosc. 1999 Aug;50(2):152-8.

PMID:
10425405
43.

Characterization of Lyme meningitis and comparison with viral meningitis in children.

Eppes SC, Nelson DK, Lewis LL, Klein JD.

Pediatrics. 1999 May;103(5 Pt 1):957-60.

PMID:
10224172
44.

Effect of precollicular transection on audiogenic seizures in genetically epilepsy-prone rats.

Browning RA, Wang C, Nelson DK, Jobe PC.

Exp Neurol. 1999 Feb;155(2):295-301.

PMID:
10072305
45.

Independent cycles of exocrine pancreatic secretion, hormones and gastroduodenal motility in healthy fasting humans: reassessment of a complex partnership.

Domínguez-Muñoz JE, Bregulla M, Nelson DK, Glasbrenner B, Sauerbruch T, Malfertheiner P.

Neurogastroenterol Motil. 1998 Feb;10(1):27-34.

PMID:
9580187
46.

Venting percutaneous gastrostomy in the treatment of refractory idiopathic gastroparesis.

Kim CH, Nelson DK.

Gastrointest Endosc. 1998 Jan;47(1):67-70. No abstract available.

PMID:
9468426
47.
48.

M1 muscarinic mechanisms regulate intestinal-phase gallbladder physiology in humans.

Nelson DK, Glasbrenner B, Dahmen G, Riepl RL, Malfertheiner P, Adler G.

Am J Physiol. 1996 Nov;271(5 Pt 1):G824-30.

PMID:
8944697
49.

M1-muscarinic mechanisms regulate interdigestive cycling of motor and secretory activity in human upper gut.

Nelson DK, Pieramico O, Dahmen G, Dominguez-Muñoz JE, Malfertheiner P, Alder G.

Dig Dis Sci. 1996 Oct;41(10):2006-15.

PMID:
8888715
50.

Nasogastric enteral feeding in the management of hyperemesis gravidarum.

Hsu JJ, Clark-Glena R, Nelson DK, Kim CH.

Obstet Gynecol. 1996 Sep;88(3):343-6.

PMID:
8752236

Supplemental Content

Loading ...
Support Center